Further Improvement in Postprandial Glucose Control With Addition of Exenatide or Sitagliptin to Combination Therapy With Insulin Glargine and Metformin: A proof-of-concept study

OBJECTIVE: To assess the effect of a 4-week adjunctive therapy of exenatide (EXE) (5–10 μg b.i.d.) or sitagliptin (SITA) (100 mg once daily) in response to a standardized breakfast meal challenge in 48 men or women with type 2 diabetes receiving insulin glargine (GLAR) + metformin (MET). RESEARCH DE...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnolds, Sabine, Dellweg, Sibylle, Clair, Janina, Dain, Marie-Paule, Nauck, Michael A., Rave, Klaus, Kapitza, Christoph
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890351/
https://www.ncbi.nlm.nih.gov/pubmed/20357372
http://dx.doi.org/10.2337/dc09-2191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890351/
https://www.ncbi.nlm.nih.gov/pubmed/20357372
http://dx.doi.org/10.2337/dc09-2191

Ejemplares similares